|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets: | |||||||
| Cash | |||||||
| Deferred offering costs | |||||||
| Prepaid expenses - current | |||||||
| Total Current Assets | |||||||
| Prepaid expenses - non-current | |||||||
| Investments held in Trust | |||||||
| Total Assets | |||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||||
| Accrued offering costs | |||||||
| Note Payable - Sponsor | |||||||
| Current Liabilities: | |||||||
| Accrued expenses | |||||||
| Total Current Liabilities | |||||||
| Deferred tax liability | |||||||
| Deferred underwriting commission payable | |||||||
| Total Liabilities | |||||||
| Class A common stock subject to possible redemption; 23,000,000 shares at redemption value | |||||||
| Common Class A | |||||||
| Common Class A Subject To Redemption | |||||||
| Total common Class A | |||||||
| Total class A common stock subject to possible redemption; 23,000,000 shares at redemption value | |||||||
| Stockholders' Deficit: | |||||||
| Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | |||||||
| Common stock | |||||||
| Common Class A | |||||||
| Class B common stock | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total Stockholders' Deficit | |||||||
| Total Liabilities and Stockholders' Deficit |
Loading...